Mexican health regulator COFEPRIS grants emergency use authorization for Merck & Co.'s anti-COVID-19 drug Molnupiravir for the treatment of severe disease. (Reuters) COVID-19 pandemic in Mexico, COVID-19 drug developmentCOVID-19 pandemic link embed save